Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Cost-effectiveness analysis

Cost-effectiveness of semaglutide versus dulaglutide for Type 2 Diabetes in China: A Markov Model analysis

Qiying Chen, Tianyu Chen, Weicheng Lin, Xi Chen

published 10 Jun 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Economic evaluation of sterilization reversal in infertility treatment: A systematic review

Brandon Chongthanadon, Suvijak Untaaveesup, Chayanis Kositamongkol, Pochamana Phisalprapa, Krasean Panyakhamlerd, Vitaya Titapant

published 01 Jun 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Choice and impact of EQ-5D-5L value set in cost-utility analyses alongside multinational trials: Insights from PREFERABLE-EFFECT and CONVINCE

Aniek E. M. Schouten, Geert W. J. Frederix, Martijn M. Stuiver, Felix Fischer, Anouk E. Hiensch, Krister Cromm, Bernard Canaud, Giovanni F. M. Strippoli, Anne M. May, Miriam P. van der Meulen, On behalf of the PREFERABLE-EFFECT Scientific Committee, and the CONVINCE Scientific Committee

published 01 Jun 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Cost-effectiveness of inclisiran in patients with atherosclerotic cardiovascular disease from Chinese healthcare perspective

Mochou Liu, Xinyue Zhang, Mengwen Feng, Qingfeng He, Zhen Feng

published 28 May 2026

Loading metrics information...

Metrics unavailable. Please check back later.

A preliminary cost-utility analysis of routine myasthenia gravis and thyroid dysfunction screening in acquired comitant Esotropia

Worapot Srimanan, Phawasutthi Keokajee, Sunita Sawangsribanterng

published 28 May 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Cost-effectiveness of various referral pathways to identify advanced fibrosis among type 2 diabetes mellitus patients with metabolic dysfunction-associated steatotic liver disease in primary care setting in Malaysia

Wei Yoon Poh, Amirah Azzeri, Shamsul Mohd Zain, Rosmawati Mohamed, Kim Sui Wan, Xe Hui Lee, Maznah Dahlui, Fatiha Hana Shabaruddin

published 28 May 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Cost-effectiveness of stem cell therapy versus standard of care for acute and subacute ischemic stroke

Soichiro Takamiya, Yasuhiro Morii, Toshiya Osanai, Kazuki Ohashi, Katsuhiko Ogasawara, Kiyohiro Houkin, Miki Fujimura

published 21 May 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Spinal mechanisms and feasibility of Dry Needling versus Botulinum Toxin Type A in post-stroke lower limb spasticity: A proof-of-concept randomized clinical trial protocol (STROKE-POC)

Clara Pujol-Fuentes, Bart Eeckhaut, Samuel Fernández Carnero, Daniel Fernández Sanchís, Theodore Wein, Pablo Herrero, Wim Saeys, Mindy F. Levin

published 20 May 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Economic evaluation of finotonlimab plus bevacizumab as first-line therapy for advanced hepatocellular carcinoma

XueYin Xu, Lian Tang, XiangHua Piao, ShaoQing Zhan, Yong Chen, PanFeng Feng

published 14 May 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Cost-effectiveness analysis of mepolizumab among patients with severe asthma from the Chinese societal perspective

Chaohao Shi, Yang Wang, Chongqing Tan, Xiaohui Zeng, Qiao Liu

published 13 May 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Costs and cost-effectiveness of the Safer Births Bundle of Care intervention in Tanzania health facilities

Boniphace Marwa, Corinna Vossius, Jan Terje Kvaløy, Benjamin Kamala, Pascal Mdoe, Hege Langli Ersdal, Frida N Ngalesoni, Albino Kalolo, Domenica Morona

published 28 Apr 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Cost-effectiveness of biofire assay for respiratory infection testing: An economic evaluation exploring the inclusion of the costs of antimirobial resistance

Raymond Oppong, Raj Gill, Kay Roy

published 27 Apr 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Cost-utility analysis of lenvatinib and sorafenib for the first-line treatment of unresectable hepatocellular carcinoma in Vietnam: Evidence from a lower-middle income country

Thang Xuan Do, Ha Thi Nguyen, Phuong Thi Lan Nguyen, Mai Thi Tuyet Kieu, Tuan Viet Duong, Van Nu Hanh Pham

published 03 Apr 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Advertisement

Create a weekly email alert for: Cost-effectiveness analysis

You can change these options by clicking profile then "Alerts and Notifications"